---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-141335"
form_type: "8-K"
ticker: null
cik: "0001779020"
company_name: "Danimer Scientific, Inc."
filed_at: "2024-12-31T23:59:59+00:00"
generated_at: "2026-05-28T21:57:29.946542+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Danimer Scientific gets NYSE delisting notice; common stock to trade on OTCQX

## Summary
- NYSE notified Danimer on Dec 30 of delisting for failing to maintain avg global market cap ≥ $15M over 30 days.
- Trading on NYSE suspended after Dec 30 close; common stock expected to trade on OTCQX under DNMR from Dec 31.
- Company assessing appeal; if no appeal, delisting effective 10 days after NYSE files Form 25 with SEC.
- Delisting does not affect business operations or SEC reporting obligations.
- Warrants (DNMRW) continue trading on OTCQX.

## SEC filing metadata
- accession: 0000950170-24-141335
- form_type: 8-K
- cik: 0001779020
- company_name: Danimer Scientific, Inc.
- filed_at: 2024-12-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/0000950170-24-141335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/dnmr-20241230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-141335
- JSON: https://secwatch.observer/filing/0000950170-24-141335.json
- Plain text: https://secwatch.observer/filing/0000950170-24-141335.txt

## Key facts
- Listing & Compliance Notices
  Danimer Scientific, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).
  - Exchange: nyse
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 802.01B
  source text: December 30, 2024, the New York Stock Exchange (“NYSE”) notified Danimer Scientific Inc. (“Danimer” or the “Company”) that it has determined to commence proceedings to delist the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listing companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading in the Common Stock on the NYSE was suspended after market close on December 30
  evidence_url: https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/0000950170-24-141335-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.